Note that Xiaflex has been approved by the FDA only for use in the United States and only for treatment of Dupuytren's contracture. In Europe the brand name is Xiapex and introduction started in May 2011. Availability schedules may vary due to country specific regulations.
Application of Xiaflex for Peyronie's disease is still under trial. There is no trial for using Xiaflex to treat Ledderhose disease.
Treatment in the USA:
US residents can find doctors/clinics providing Xiaflex on http://www.xiaflex.com/
Treatment in Canada:
Xiaflex has been approved for use in Canada on July 9, 2012, and the drug is now becoming available in Canada background_info. We are not aware of a list on the Internet where patients can find addresses of clinics providing collagenase injection. Interested Canadian patients might inquire with the Canadian distributor, Actelion Pharmaceuticals Canada, 2550 Daniel Johnson Blvd., Laval, Quebec, Canada H7T 2L1, Phone 1-866-531-4885.
We have no information to what extent the Canadian health system will pay for Xiaflex but there seem to be some concerns about pricing cost_effectiveness_Canada.
Treatment in Australia:
As of November 2013 collagenase has been approved in Australia for the treatment of Dupuytren's contracture in adult patients with a palpable cord. The drug is not reimbursed by the government at this stage. More details are on the NPS_website. We don't know which doctors are currently providing this drug. Interested patients might inquire with Actelion Pharmaceuticals Australia, Phone: +61 2 9486 4600.
Treatment in Europe:
Collagenase has been approved by the EU for treating Dupuytren's contracture press_release. To make it available for treatment requires additional national documentations by country which may take several months or even more than a year, depending on country. For the time being it might make sense, irrespective of the country, to clarify to what extent the health insurance is covering the treatment.
If you are suffering from Dupuytren's contracture and are interested in participating in collagenase trials you might register on a special Pfizer web page European_trial_reg. The trial description is on European_trial. In Europe the collagenase product is currently distributed by Pfizer (until April 2013) and named Xiapex.
Pfizer withdrew Xiapex from the German market. This was not for health but for price reasons. A few German clinics are now importing Xiapex from other European countries German-clinics. German insurances are in part reluctant to pay for Xiapex (GKV type insurances).
As we have been contacted about treatment possibilities in the Netherlands and UK specifically, here are a few addresses (sorted alphabetically by town), which already have experience with collagenase.You might also visit the website of the British Dupuytren Society.
Dept of Plastic Surgery
Prof. Dr. P.M.N. Werker
9700 RB Groningen
Phone: +31.50.3613220 (for appointments)
Mr. Mike Hayton
The Alexandra Hospital
Mill Lane, Cheadle
Cheshire SK8 2PX
Hall Lane, Appley Bridge
Wigan WN6 9EP
Phone: (0161) 495 7766
Mr. Chris Bainbridge
Pulvertaft Hand Centre
Derbyshire Royal Infirmary
Phone: (01332) 347141
Mr. H.J.C.R. Belcher (MS, FRCS)
Queen Victoria Foundation Trust Hospital (NHS)
East Grinstead, Sussex RH19 3DZ
Phone: (01342) 414236 (NHS)
Phone: (01342) 851088 (private consulting)
Mr. Mark Broadbent
Nuffield Hospital Glasgow
25 Beaconsfield Road
Glasgow G12 0PJ
Phone: (0141) 334 9441
info /at/ glasgowandclydehandclinics.co.uk
Mr. Henk Giele
Oxford Radcliffe Hospitals and Nuffield Orthopaedic Centre NHS trusts,
Nuffield Manor BMI Oxford and Circle Windsor Hand Clinic Private Hospitals
Oxford and Windsor
Mr. David Warwick
Hand Clinic, Wessex Nuffield Hospital
Southampton, SO53 2DW
Phone: (0845) 4505007
Please refer to our German web site
We will update the release information for Xiapex continously.
Page last modified: 11/24/2013